Bridgefront Capital’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$303K Sell
1,688
-1,319
-44% -$225K 0.08% 389
2025
Q4
$425K Buy
+3,007
New +$341K 0.11% 305
2025
Q3
Sell
-11,603
Closed -$727K 570
2025
Q2
$727K Buy
11,603
+7,482
+182% +$442K 0.19% 177
2025
Q1
$297K Buy
+4,121
New +$335K 0.09% 400
2024
Q3
Sell
-3,021
Closed -$289K 515
2024
Q2
$289K Buy
+3,021
New +$359K 0.12% 306
2023
Q3
Sell
-1,482
Closed -$331K 379
2023
Q2
$331K Buy
+1,482
New +$303K 0.18% 222
2021
Q2
Sell
-2,225
Closed -$325K 587
2021
Q1
$325K Sell
2,225
-1,524
-41% -$245K 0.1% 401
2020
Q4
$553K Buy
+3,749
New +$445K 0.19% 179

Other funds holding ALB

Bridgefront Capital's ALB Position: Q1 2026 in Review

Bridgefront Capital reduced its Albemarle (ALB) stake by 44% in Q1 2026, selling an estimated $225K and leaving 1,688 shares worth $303K. The position accounts for 0.08% of the portfolio, ranked #389.

Bridgefront Capital first reported a position in ALB in Q4 2020 and has held it in 8 quarters since. The position peaked at $727K in Q2 2025. 982 funds tracked by Wall St. Rank hold ALB as of Q1 2026.

  • Bridgefront Capital held 1,688 shares of Albemarle worth $303K as of Q1 2026.
  • Bridgefront Capital sold 1,319 Albemarle shares in Q1 2026, an estimated $225K.
  • Albemarle made up 0.08% of Bridgefront Capital's portfolio in Q1 2026, its #389 holding.
  • Bridgefront Capital first reported a position in Albemarle in Q4 2020 and has held it in 8 quarters since.
  • Bridgefront Capital's Albemarle position peaked at $727K in Q2 2025.
  • 982 funds tracked by Wall St. Rank held Albemarle as of Q1 2026.

Based on Bridgefront Capital's 13F filing for Q1 2026, filed 15 May 2026.